Filippo G. De Braud
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 491 publications
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2026
First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies.
Journal: Journal for immunotherapy of cancer
Published: April 27, 2026
CAR-engineering of innate and innate-like immune cells: a new horizon in adoptive cell therapy for solid tumors.
Journal: Journal for immunotherapy of cancer
Published: April 18, 2026
Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Nectin-4 and Trop-2 expression in collecting duct carcinoma: new promising therapeutic targets.
Journal: ESMO open
Published: March 30, 2026
Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Network analysis predicts pembrolizumab response in advanced NSCLC with PD-L1 < 50.
Journal: Cancer cell international
Published: November 06, 2025
Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models.
Journal: Communications medicine
Published: October 24, 2025
Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategies.
Journal: Cancer treatment reviews
Published: September 23, 2025
UpSMART: five years of digital innovation in cancer clinical research-achievements, challenges, and recommendations.
Journal: Frontiers in digital health
Published: September 18, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.
Journal: Cancers
Published: July 14, 2025
Last Updated: 09/26/2026